CO5050294A1 - NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES - Google Patents

NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES

Info

Publication number
CO5050294A1
CO5050294A1 CO99035396A CO99035396A CO5050294A1 CO 5050294 A1 CO5050294 A1 CO 5050294A1 CO 99035396 A CO99035396 A CO 99035396A CO 99035396 A CO99035396 A CO 99035396A CO 5050294 A1 CO5050294 A1 CO 5050294A1
Authority
CO
Colombia
Prior art keywords
group
alkyl
amino
substituted
phenyl
Prior art date
Application number
CO99035396A
Other languages
Spanish (es)
Inventor
Armin Heckel
Rainer Walter
Wolfgang Grell
Meel Jacobus C A Van
Norber Redemann
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of CO5050294A1 publication Critical patent/CO5050294A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2

Abstract

Indolinonas sustituidas de la fórmula generalen la queX significa un átomo de oxígeno o azufreR1 significa un átomo de hidrógeno, un grupo alcoxi C1-4 AND#150;carbonilo o alcanoílo C2-4 , R2 significa un grupo carboxi o alcoxi C1-4 AND#150;carbonilo, o un grupo aminocarbonilo eventualmente sustituido con uno o dos grupos alquilo C1-3 , en donde los sustituyentes pueden ser iguales o diferentes,R3 significa un átomo de hidrógeno o un grupo alquilo C1-6 que, a partir de la posición 2 referida al átomo de carbono del grupo R3 AND#150;C(R4 NR5 )=, puede estar sustituido con un átomo de flúor, cloro o bromo, con un grupo hidroxi, alcoxi C1-3 , alquil C1-3 AND#150;sulfenilo, alquil C1-3 AND#150;sulfinilo, alquil C1-3 AND#150;sulfonilo, fenilsulfenilo, fenilsulfinilo, amino, alquil C1-3 AND#150;amino, di-(alquil C1-3 )-amino, alcanoil C2-5 AND#150;amino o N-(alquil C1-3 AND#150; amino)-alcanoil C2-5 AND#150;amino,R4 significa un átomo de hidrógeno, un grupo alquilo C1-6 o un grupo cicloalquilo C5-7 eventualmente sustituido con un grupo alquilo C1-3 , en el que un grupo metilo en la posición 3 ó 4 referida al átomo de carbono del grupo R3 AND#150;C(R4 NR5 )=, puede estar sustituido con un grupo imino eventualmente sustituido con un grupo alquilo C1-3 ,un grupo fenilo o naftilo, que puede estar sustituido con un átomo de flúor, cloro, bromo o yodo,con un grupo metoxi, eventualmente sustituido con 1 a 3 átomos de flúor,con un grupo alcoxi C2-3 que, en posición 2 ó 3, puede estar sustituido con un grupo alquil C1-3 AND#150; amino, di-(alquil C1-3 )-amino o cicloalquilenimino de 5 a 7 miembros, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos alquilamino y dialquilamino precedente mencionados puede estar sustituida con un grupo fenilo,con un grupo trifluorometilo, amino, alquil C1-3 AND#150; amino, di-(alquil C1-3 )-amino, alcanoil C2-5 AND#150;amino, - 2 -N-(alquil C1-3 )-alcanoil C2-5 AND#150;amino, alquil C1-5 AND#150; sulfonilamino, N-(alquil C1-3 )-alquil C1-5 AND#150; sulfonilamino, fenilsulfonilamino, N-alquil C1-3 )-fenilsulfonilamino, aminosulfonilo, alquil C1-3 AND#150; amino-sulfonilo o di-(alquil C1-3 )-aminosulfonilo, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos alquilamino y dialquilamino precedentemente mencionados puede estar sustituida con un grupo fenilo,con un grupo carbonilo, que está sustituido con un grupo hidroxi, alcoxi C1-3 , amino, alquil C1-3 AND#150;amino o N-(alquil C1-5 )-alquil C1-3 AND#150;amino, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos precedentemente mencionados puede estar sustituida con un grupo carboxi, alcoxi C1-3 AND#150; carbonilo o fenilo o, en posición 2 ó 3, con un grupo di-(alquil C1-3 )-amino, piperazino, N-(alquil C1-3 )-piperazino o cicloalquilenimino de 5 a 7 miembros, con un grupo alquilo C1-3 , que está sustituido con un grupo amino, alquil C1-7 AND#150;amino, cicloalquil C5-7 AND#150;amino o fenil-alquil C1-3 AND#150;amino, que en cada caso puede estar sustituido adicionalmente en el átomo de nitrógeno con un grupo alquilo C1-3 , en el que los átomos de hidrógeno están reemplazados, parcial o totalmente, por átomos de flúor, con un grupo cicloalquilo C5-7 , alquenilo C2-4 o alquilo C1-4 en donde el sustituyente alquilo C1-4 precedentemente mencionado puede estar sustituido en cada caso adicionalmente con un grupo ciano, carboxi, alcoxi C1-3 -carbonilo, piridilo, imidazolilo, benzo[1,3]dioxol o fenilo, pudiendo estar el grupo fenilo mono-, di- o tri-sustituido con átomos de flúor, cloro o bromo, con un grupo metilo, metoxi, trifluorometilo, ciano o nitro, y los sustituyentes pueden ser iguales o diferentes, o puede estar sustituido en posición 2, 3 ó 4 con un grupo hidroxi,con un grupo alquilo C1-3 que puede estar sustituido con un grupo hidroxi, carboxi, tiomorfolino, 1-óxido-tiomorfolino, 1,1-dióxido-tiomorfolino, piperazino, N-(alquil C1-3 )-piperazino o N-fenil-piperazino, con un grupo cicloalquilenimino de 5 a 7 miembros o con un grupo cicloalquilenimino de 4 a 7 miembros, en donde los grupos cicloalquilenimino de 5 a 7 miembros precedentemente mencionados pueden estar sustituidos con uno o dos grupos alquilo C1-3 , con un grupo cicloalquilo C5-7 o fenilo, con un grupo alquilo C1-3 , cicloalquilo C5-7 , fenilo carboxi o alcoxi C1-4 -carbonilo y con un grupo hidroxi, y en los grupos cicloalquilenimino precedentemente mencionados un grupo metileno contiguo al átomo de nitrógeno puede estar reemplazado por un grupo carbonilocon un grupo alquilo C 1-3 , que está sustituido con un grupo cicloalquilenimino de 5 a 7 miembros, estando condensado a los grupos cicloalquilenimino de 5 a 7 miembros precedentemente mencionados, a través de 2 átomos de carbono continuos, un grupo fenilo eventualmente mono- o di-sustituido con átomos de flúor cloro o bromo, con grupos metilo o metoxi, pudiendo ser los sustituyentes iguales o diferentes, o un grupo oxazolo, imidazolo, tiazolo, piridino, pirazino o pirimidino eventualmente sustituido con un grupo metilo, metoxi o amino, pudiendo estar sustituido adicionalmente los grupos fenilo monosustituidos, precedentemente mencionados, con un átomo de flúor, cloro o bromo, con un grupo metilo, metoxi o nitro, un grupo heteroaromático de 5 miembros, que contiene un grupo imino, un átomo de oxígeno o azufre, o un grupo imino, un átomo de oxígeno o azufre y uno o dos átomos de nitrógeno, o un grupo heteroaromático de 6 miembros, que contiene uno, dos o tres átomos de nitrógeno, en donde los grupos heteroaromáticos de 5 y 6 miembros precedentemente mencionados pueden estar sustituidos adicionalmente con un átomo de cloro bromo o con un grupo metilo, o a los grupos heteroaromáticos de 5 a 6 miembros precedentemente mencionados puede estar condensado un anillo de fenilo a través de 2 átomos de carbono contiguos, yR5 significa un átomo de hidrógeno o un grupo alquilo C1-3 , pudiendo estar sustituidos los grupos carboxi, amino o imino presentes con radicales separables in vivo,sus isómeros y sus sales.Substituted indolinones of the formula generally where X means an oxygen or sulfur atom R1 means a hydrogen atom, a C1-4 AND # 150 alkoxy group; C2-4 carbonyl or alkanoyl, R2 means a carboxy or C1-4 AND # alkoxy group 150; carbonyl, or an aminocarbonyl group optionally substituted with one or two C1-3 alkyl groups, wherein the substituents may be the same or different, R3 means a hydrogen atom or a C1-6 alkyl group which, from the position 2 referred to the carbon atom of the group R3 AND # 150; C (R4 NR5) =, may be substituted with a fluorine, chlorine or bromine atom, with a hydroxy group, C1-3 alkoxy, C1-3 alkyl AND # 150 ; sulfenyl, C1-3 alkyl # 150; sulfinyl, C1-3 alkyl AND # 150; sulfonyl, phenylsulfenyl, phenylsulfinyl, amino, C1-3 alkyl AND # 150; amino, di- (C1-3 alkyl) -amino, C2-5 alkanoyl AND # 150; amino or N- (C1-3 alkyl AND # 150; amino) -C2-5 alkanoyl AND # 150; amino, R4 means a hydrogen atom, a C1-6 alkyl group or a gru po C5-7 cycloalkyl optionally substituted with a C1-3 alkyl group, in which a methyl group in position 3 or 4 referred to the carbon atom of the group R3 AND # 150; C (R4 NR5) =, may be substituted with an imino group optionally substituted with a C1-3 alkyl group, a phenyl or naphthyl group, which may be substituted with a fluorine, chlorine, bromine or iodine atom, with a methoxy group, optionally substituted with 1 to 3 fluorine atoms, with a C2-3 alkoxy group which, in position 2 or 3, may be substituted with a C1-3 alkyl group AND # 150; amino, di- (C1-3 alkyl) -amino or cycloalkyleneimino of 5 to 7 members, wherein, in each case, additionally a part of alkyl in the aforementioned alkylamino and dialkylamino groups may be substituted with a phenyl group, with a trifluoromethyl group, amino, C1-3 alkyl AND # 150; amino, di- (C1-3 alkyl) -amino, C2-5 alkanoyl AND # 150; amino, - 2 -N- (C1-3 alkyl) -C2-5 alkanoyl AND # 150; amino, C1-5 AND alkyl # 150; sulfonylamino, N- (C1-3 alkyl) -C1-5 alkyl AND # 150; sulfonylamino, phenylsulfonylamino, N-C1-3 alkyl) -phenylsulfonylamino, aminosulfonyl, C1-3 alkyl AND # 150; amino-sulfonyl or di- (C1-3-alkyl) -aminosulfonyl, wherein, in each case, additionally a part of alkyl in the aforementioned alkylamino and dialkylamino groups may be substituted with a phenyl group, with a carbonyl group, which is substituted with a hydroxy group, C1-3 alkoxy, amino, C1-3 alkyl AND # 150; amino or N- (C1-5 alkyl) -C1-3 alkyl AND # 150; amino, where, in each case, additionally an alkyl part in the aforementioned groups may be substituted with a carboxy group, C1-3 alkoxy AND # 150; carbonyl or phenyl or, in position 2 or 3, with a di- (C1-3 alkyl) -amino, piperazino, N- (C1-3 alkyl) -piperazino or cycloalkyleneimino group of 5 to 7 members, with a C1-alkyl group -3, which is substituted with an amino group, C1-7 alkyl AND # 150; amino, C5-7 cycloalkyl AND # 150; amino or phenyl-C1-3 alkyl AND # 150; amino, which in each case may be substituted additionally in the nitrogen atom with a C1-3 alkyl group, in which the hydrogen atoms are partially or totally replaced by fluorine atoms, with a C5-7 cycloalkyl, C2-4 alkenyl or C1-4 alkyl group wherein the above-mentioned C1-4 alkyl substituent may be additionally substituted in each case with a cyano, carboxy, C1-3 alkoxycarbonyl, pyridyl, imidazolyl, benzo [1,3] dioxol or phenyl group, the phenyl group may be mono-, di- or tri-substituted with fluorine, chlorine or bromine atoms, with a methyl, methoxy, trifluoromethyl, cyano or nitro group, and the substituents can n be the same or different, or it may be substituted in position 2, 3 or 4 with a hydroxy group, with a C1-3 alkyl group which may be substituted with a hydroxy, carboxy, thiomorpholino, 1-oxide-thiomorpholino group, 1, 1-Dioxide-thiomorpholino, piperazino, N- (C1-3 alkyl) -piperazino or N-phenyl-piperazino, with a cycloalkyleneimino group of 5 to 7 members or with a cycloalkyleneimino group of 4 to 7 members, wherein cycloalkyleneimino groups 5 to 7 members mentioned above may be substituted with one or two C1-3 alkyl groups, with a C5-7 cycloalkyl or phenyl group, with a C1-3 alkyl, C5-7 cycloalkyl, carboxy phenyl or C1-4 alkoxy group -carbonyl and with a hydroxy group, and in the aforementioned cycloalkyleneimino groups a methylene group contiguous with the nitrogen atom may be replaced by a carbonyl group with a C 1-3 alkyl group, which is substituted with a 5 to 7 membered cycloalkyleneimino group , being condensed to the group s 5 to 7 cycloalkyleneimino mentioned above, through 2 continuous carbon atoms, a phenyl group optionally mono- or di-substituted with chlorine or bromine fluorine atoms, with methyl or methoxy groups, the substituents being the same or different , or an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted with a methyl, methoxy or amino group, the monosubstituted phenyl groups, mentioned above, being additionally substituted with a fluorine, chlorine or bromine atom, with a methyl, methoxy or nitro group, a 5-membered heteroaromatic group, which contains an imino group, an oxygen or sulfur atom, or an imino group, an oxygen or sulfur atom and one or two nitrogen atoms, or a heteroaromatic group 6-member, containing one, two or three nitrogen atoms, wherein the aforementioned 5 and 6 member heteroaromatic groups may be additionally substituted With a bromine chlorine atom or with a methyl group, or to the above mentioned 5 to 6 member heteroaromatic groups, a phenyl ring may be condensed through 2 contiguous carbon atoms, and R5 means a hydrogen atom or an alkyl group C1-3, the carboxy, amino or imino groups present with separable radicals in vivo, their isomers and their salts may be substituted.

CO99035396A 1998-06-04 1999-06-04 NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES CO5050294A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19824922A DE19824922A1 (en) 1998-06-04 1998-06-04 Novel substituted indolinones, their preparation and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
CO5050294A1 true CO5050294A1 (en) 2001-06-27

Family

ID=7869856

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99035396A CO5050294A1 (en) 1998-06-04 1999-06-04 NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES

Country Status (23)

Country Link
EP (1) EP1100779A1 (en)
JP (1) JP2002516906A (en)
KR (1) KR20010043973A (en)
CN (1) CN1303374A (en)
AU (1) AU764782B2 (en)
BG (1) BG104938A (en)
BR (1) BR9910898A (en)
CA (1) CA2328291A1 (en)
CO (1) CO5050294A1 (en)
DE (1) DE19824922A1 (en)
EA (1) EA003514B1 (en)
EE (1) EE200000723A (en)
HR (1) HRP20000831A2 (en)
HU (1) HUP0102210A3 (en)
ID (1) ID27035A (en)
IL (1) IL138702A0 (en)
NO (1) NO20006138L (en)
PL (1) PL344467A1 (en)
SK (1) SK18222000A3 (en)
TR (1) TR200003515T2 (en)
WO (1) WO1999062882A1 (en)
YU (1) YU73900A (en)
ZA (1) ZA200005435B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816624A1 (en) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Novel substituted indolinones, their preparation and their use as pharmaceuticals
GB9904933D0 (en) * 1999-03-04 1999-04-28 Glaxo Group Ltd Compounds
US6624171B1 (en) 1999-03-04 2003-09-23 Smithkline Beecham Corporation Substituted aza-oxindole derivatives
US6762180B1 (en) 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
UA75054C2 (en) 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Substituted in position 6 indolinones, producing and use thereof as medicament
JP2004508366A (en) * 2000-09-01 2004-03-18 グラクソ グループ リミテッド Oxindole derivatives
AU2001288374A1 (en) 2000-09-01 2002-03-22 Glaxo Group Limited Substituted oxindole derivatives as tyrosine kinase inhibitors
DE10117204A1 (en) * 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma Indolinones substituted in the 6-position, their preparation and their use as medicaments
JP2004537537A (en) * 2001-06-29 2004-12-16 アブ サイエンス Uses of tyrosine kinase inhibitors to treat inflammatory diseases
US7700610B2 (en) 2001-06-29 2010-04-20 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
JP2004536097A (en) * 2001-06-29 2004-12-02 アブ サイエンス Uses of tyrosine kinase inhibitors to treat autoimmune diseases
US7678805B2 (en) 2001-06-29 2010-03-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)
ATE376182T1 (en) 2001-06-29 2007-11-15 Ab Science C-KIT INHIBITORS
US6765012B2 (en) 2001-09-27 2004-07-20 Allergan, Inc. 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
JP4879492B2 (en) * 2002-11-27 2012-02-22 アラーガン、インコーポレイテッド Kinase inhibitors for the treatment of diseases
DE102004012070A1 (en) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cycloalkyl-containing 5-acylindolinones, their preparation and their use as medicaments
PE20060777A1 (en) * 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
CN101547892B (en) * 2006-12-05 2014-08-20 艾尼纳制药公司 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
GB0706072D0 (en) * 2007-03-28 2007-05-09 Sterix Ltd Compound
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
CN101735071A (en) * 2009-12-04 2010-06-16 大连凯飞精细化工有限公司 Method for producing 4-N,N-dimethylamino methylaniline
CN103102352B (en) * 2011-11-15 2015-08-12 山东亨利医药科技有限责任公司 Tyrosine kinase inhibitor indolinone derivative
CN103130775B (en) * 2011-11-22 2015-09-30 山东亨利医药科技有限责任公司 As the dihydroindole ketone derivate of tyrosine kinase inhibitor
GB201208775D0 (en) 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
CN103848814B (en) * 2012-12-06 2016-08-17 山东亨利医药科技有限责任公司 The full ketone derivatives of substituted indole as tyrosine kinase inhibitor
WO2024050297A1 (en) * 2022-09-02 2024-03-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE838623A (en) * 1976-02-16 1976-06-16 3-HYDROXYMETHYLENE-2-INDOLINONE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
US4145422A (en) * 1977-09-06 1979-03-20 Abbott Laboratories Aminomethylene oxindoles
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
AU4155697A (en) * 1996-08-23 1998-03-06 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
TR200003515T2 (en) 2001-06-21
NO20006138L (en) 2001-02-01
CN1303374A (en) 2001-07-11
JP2002516906A (en) 2002-06-11
IL138702A0 (en) 2001-10-31
ZA200005435B (en) 2002-01-07
HRP20000831A2 (en) 2001-12-31
CA2328291A1 (en) 1999-12-09
EA003514B1 (en) 2003-06-26
ID27035A (en) 2001-02-22
EE200000723A (en) 2002-04-15
EP1100779A1 (en) 2001-05-23
AU4370799A (en) 1999-12-20
YU73900A (en) 2003-04-30
HUP0102210A2 (en) 2001-11-28
BR9910898A (en) 2001-02-13
SK18222000A3 (en) 2001-08-06
KR20010043973A (en) 2001-05-25
BG104938A (en) 2001-06-29
NO20006138D0 (en) 2000-12-01
DE19824922A1 (en) 1999-12-09
WO1999062882A1 (en) 1999-12-09
AU764782B2 (en) 2003-08-28
EA200100001A1 (en) 2001-08-27
PL344467A1 (en) 2001-11-05
HUP0102210A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
CO5050294A1 (en) NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES
CO5580788A2 (en) BENCIMIDAZOL COMPOUNDS REPLACED USEFUL AS PROTEIN CINASE INHIBITORS
AR013199A1 (en) SULFONAMIDES COMPOUND, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR059778A1 (en) PIRROLOTRIAZINE COMPOUNDS INHIBITORS OF P38 KINASES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN GREAT VARIETY OF INFLAMMATORY PROCESSES.
AR055071A1 (en) PIRROLO DERIVATIVES (3,2 - B) PYRIMIDINE. PHARMACEUTICAL COMPOSITIONS.
BR0208309A (en) Arylisoxazoline derivatives, processes for their preparation and their application as pesticides
DE60315265D1 (en) NITROGENIC HETEROCYCLIC COMPOUND AND MEDICINES THEREOF
AR041027A1 (en) 1,2,3-TRIAZOL DERIVATIVES WITH PARTICULARLY FUNGICIATED ANTIMICROBIAL ACTIVITY
AR052177A1 (en) MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
CY1112006T1 (en) MACROCYCLIC INHIBITORS OF USITIS C virus
AR074902A1 (en) DERIVATIVES OF 1,2,4-OXADIAZOLS AGONISTS OF RECEIVERS S1P1
AR057357A1 (en) HITEROCICLES NITROGENATED AS INHIBITORS OF HETEROARIL 11-BETA HYDROXIESTEROID DEHYDROGENASE TYPE 1. PHARMACEUTICAL COMPOSITIONS
AR041250A1 (en) SULFONAMIDE DERIVATIVES AS INHIBITORS OF TNF-ALFA CONVERTER ENZYMES
PE20090042A1 (en) CYCLOPAMINE ANALOGS
CO5611110A2 (en) GLUCOCORTICOID MIMETICS, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
CO5070570A1 (en) THYROSINE DERIVATIVES AS ACTIVATORS OF hPPAR AND hPPARALFA AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM
AR069919A1 (en) BIS- (SULFONYLAMINE) DERIVATIVES USEFUL FOR PAIN TREATMENT
BRPI0211844B8 (en) compound of phenoxy-acetic acid or one of its pharmaceutically acceptable salts, and, pharmaceutical composition
AR035417A1 (en) TRICYCLE DERIVATIVES OF LACTAMA AND SULTAMA, PROCESSES FOR THEIR DEVELOPMENT, DRUGS THAT CONTAIN THEM, AND THE USE OF SUCH COMPOUNDS IN THE PREPARATION OF DRUGS
EA200970379A1 (en) BICYCLIC HETEROAROMATIC COMPOUNDS
CO5690577A2 (en) IMIDAZOQUINOLINE DERIVATIVES AS ADENOSINE A3 RECEIVING LIGANDS
CO5031250A1 (en) PHARMACEUTICAL COMPOUND
CO5690593A2 (en) NEW DERIVATIVES OF PIRIMIDIN 2-AMINA
DE602007004740D1 (en) ANTIBIOTIC SPIRO DERIVATIVES
AR060438A1 (en) 2- (PIRIDIN-2-IL) - PYRIMIDINS AS FUNGICIDES.